Oxford Covid Vaccine: Serum Institute Gets Nod For Phase 2, 3 Human Trial

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the...

from NDTV News - Latest https://ift.tt/2XmSgN8
via